21st Century Cures leaders vow to work out differences
This article was originally published in Scrip
Executive Summary
The two members of the House who have been leading an effort to overhaul certain functions at the FDA and the National Institutes of Health and other areas of the US biomedical research and development enterprise wit the goal of accelerating the discovery, development and delivery of medical therapies have vowed to work out their differences and move the legislative process forward.